S.H. Rosenberg
Impact in
- Hematology top 10%
- Platelet Disorders and Treatments
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Receptor Mechanisms and Signaling 2
- Cancer therapeutics and mechanisms 2
- 14-3-3 protein interactions 1
- Cell death mechanisms and regulation 1
-
- Renin-Angiotensin System Studies 4
- Co-authors
- Steven W. Elmore (1 shared paper)Laurie Iciek (1 shared paper)Glenn A. Reinhart (1 shared paper)S. J. Morgan (1 shared paper)Paul Nimmer (1 shared paper)Ryan M. Fryer (1 shared paper)Lee C. Preusser (1 shared paper)Morey L. Smith (1 shared paper)
- Journals
- European Journal of Cancer (3 papers)Clinical Chemistry (1 paper)Cell Death and Differentiation (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
S.H. Rosenberg
11 papers receiving 613 citations
Peers
Comparison fields: 5 of 72
- Hematology 137
- Genetics 71
- Oncology 167
- Molecular Biology 355
- Ophthalmology 34
Countries citing papers authored by S.H. Rosenberg
This map shows the geographic impact of S.H. Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.H. Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.H. Rosenberg more than expected).
Fields of papers citing papers by S.H. Rosenberg
This network shows the impact of papers produced by S.H. Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.H. Rosenberg. The network helps show where S.H. Rosenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside S.H. Rosenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 351 | |
| 2 | A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors. | 2001 | 60 |
| 3 | 2000 | 46 | |
| 4 | Retinoblastoma. The relationship of proliferating cells to blood vessels. | 1990 | 43 |
| 5 | 1999 | 42 | |
| 6 | 2004 | 41 | |
| 7 | 1988 | 19 | |
| 8 | 2000 | 13 | |
| 9 | 1990 | 6 | |
| 10 | 2004 | 5 | |
| 11 | 1992 | 2 | |
| 12 | 1990 | 0 |
About S.H. Rosenberg
S.H. Rosenberg is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology, Cell Biology and Biochemistry, having authored 12 papers that have together received 628 indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (4 papers), Microtubule and mitosis dynamics (2 papers), Receptor Mechanisms and Signaling (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Cancer therapeutics and mechanisms (2 papers), Click Chemistry and Applications (1 paper), 14-3-3 protein interactions (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Hematology (137 citations), Genetics (71 citations), Oncology (167 citations), Molecular Biology (355 citations) and Ophthalmology (34 citations). S.H. Rosenberg has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Steven W. Elmore, Laurie Iciek, Glenn A. Reinhart, S. J. Morgan, Paul Nimmer, Ryan M. Fryer, Lee C. Preusser, Morey L. Smith, Christin Tse and Randy Nelson. Their work appears in journals such as European Journal of Cancer, Clinical Chemistry, Cell Death and Differentiation, Journal of Pharmacology and Experimental Therapeutics and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.